Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cy5 5 carboxylic acid non sulfonated 25mg'

Search results for: 'cy5 5 carboxylic acid non sulfonated 25mg'

Items 151-160 of 161

Page
per page
  1. Chidamide
    B5916 Chidamide
     1 Citation
    Target: HDAC
    Summary: Novel HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18.55 mg/mL
  2. WDR5 0103
    B4949 WDR5 0103
    Summary: WD repeat-containing protein 5 (WDR5) antagonist
  3. CUDC-907
    A4097 CUDC-907
    Target: Histone Deacetylases (HDACs)|PI3K
    Summary: Potent PI3K/HDAC inhibitor
      ≥25.45 mg/mL
  4. Molidustat (BAY85-3934)
    B5861 Molidustat (BAY85-3934)
    Target: HIF-PH
    Summary: Novel HIF-PH inhibitor
  5. I-CBP 112
    A4490 I-CBP 112
    Target: CREBBP|EP300
    Summary: CBP/EP300 bromodomain inhibitor
      ≥49.6 mg/mL
  6. EPZ5676
    A4166 EPZ5676
     1 Citation
    Target: DOT1L
    Summary: DOT1L inhibitor,potent and SAM competitive
      ≥28.15 mg/mL
  7. FG-4592 (ASP1517)
    A4187 FG-4592 (ASP1517)
     1 Citation
    Summary: HIF prolyl-hydroxylase inhibitor
      insoluble in H2O; ≥17.62 mg/mL
  8. Bardoxolone methyl
    A3221 Bardoxolone methyl
    Target: Nrf2
    Summary: IKK inhibitor, potent antioxidant inflammation modulator
      ≥25.3 mg/mL
  9. ML 228
    A4508 ML 228
    Summary: HIF pathway activator
      Soluble in DMSO
  10. LAQ824 (NVP-LAQ824,Dacinostat)
    A4103 LAQ824 (NVP-LAQ824,Dacinostat)
     1 Citation
    Summary: HDAC inhibitor,potent and novel
      insoluble in H2O; insoluble in EtOH; ≥17.45 mg/mL

Items 151-160 of 161

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 15item
  2. Aurora Kinase 10item
  3. DNA Methyltransferase 6item
  4. HDAC 28item
  5. Histone Acetyltransferases 8item
  6. Histone Demethylases 10item
  7. Histone Methyltransferase 26item
  8. HIF 5item
  9. JAK 13item
  10. MBT Domains 1 item
  11. PARP 7item
  12. Pim 4item
  13. Protein Ser/Thr Phosphatases 13item
  14. Sirtuin 10item
  15. Sphingosine Kinase-2 1 item
  16. Polycomb repressive complex 2item
  17. SUMOylation 2item
Specificity
  1. Selective 54item
Reversibility
  1. Reversible 3item
  2. Irreversible 1 item
Target
  1. Histone Deacetylases (HDACs) 17item
  2. PI3K 1 item
  3. Aurora Kinases 6item
  4. EZH2 3item
  5. Bromodomains 5item
  6. FLT3 2item
  7. VEGFR 1 item
  8. Hydrolase 1 item
  9. MEK 1 item
  10. DOT1L 2item
  11. FGFR 1 item
  12. Nrf2 1 item
  13. Pim 3item
  14. Sir2-like Family Deacetylases (Sirtuins) 3item
  15. Src 2item
  16. Trk Receptors 1 item
  17. STAT 1 item
  18. JAK 6item
  19. EZH1 1 item
  20. TNKS 1 item
  21. DNA Methyltransferases 2item
  22. SMYD2 1 item
  23. CREBBP 1 item
  24. EP300 1 item
  25. PARP 1 item
  26. ALK 1 item
  27. Bromodomain and Extra-Terminal motif (BET) 1 item
  28. NAT10 1 item
  29. G9a 1 item
  30. SETD7 1 item
  31. Histone Demethylases 1 item
  32. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  33. Protein Arginine Methyltransferases 1 item
  34. c-RET 1 item
  35. p53 1 item
  36. HDAC 2item
  37. KDM 2item
  38. Histone Acetyltransferases (HATs) 1 item
  39. HIF-PH 1 item
  40. TYK2 1 item
  41. MUSK 1 item
  42. MAP3K 1 item
  43. Lck 1 item
  44. p21 1 item
  45. PHF 1 item
  46. LSD 1 item
  47. PRMT 1 item
  48. SK 1 item
  49. Sirtuin 1 item
Reported Experiments
  1. Animal Experiments 56item
  2. Cell Experiments 46item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 8item
  3. Bladder Cancer 1 item
  4. Breast Cancer 9item
  5. Cancer 44item
  6. Castration-resistant Prostate Cancer 1 item
  7. Cervical Cancer 2item
  8. Colon Cancer 1 item
  9. Colon Carcinoma 1 item
  10. Colorectal Cancer 4item
  11. Diffuse Large B-cell Lymphoma 1 item
  12. Dyskinesia 1 item
  13. Epilepsy 1 item
  14. Friedreich's Ataxia 1 item
  15. Glioblastoma 1 item
  16. Glioma 1 item
  17. Hepatocellular Carcinoma 1 item
  18. HIV 2item
  19. HIV Infections 2item
  20. Inflammatory Diseases 2item
  21. Leukemia 1 item
  22. Lung Cancer 1 item
  23. Lymphoma 4item
  24. Melanoma 4item
  25. Mixed Lineage Leukemia 2item
  26. Multiple Myeloma 4item
  27. Myelofibrosis 1 item
  28. Neuroblastoma 1 item
  29. Non-small Cell Lung Cancer 3item
  30. Ovarian Cancer 2item
  31. Pancreatic Cancer 3item
  32. Prostate Cancer 6item
  33. Psoriasis 1 item
  34. Renal Cell Carcinoma 2item
  35. Rheumatoid Arthritis 1 item
  36. Thyroid Cancer 1 item
  37. Type 2 Diabetes 1 item